Moligand™, 10 mM in DMSO Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Protected from light,Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 9 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Glutathione ethyl ester is a cell-permeable GSH donor and provides an efficient supply of GSH to the oocyte. Glutathione ethyl ester shows positive effect on the in vitro production of embryos by enhancement of the antioxidative defense.
| Isómeros SMILES | CCOC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(=O)O)N |
|---|---|
| WGK Alemania | 3 |
| Peso molecular | 335.38 |
| Reaxy-Rn | 25642856 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=25642856&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| 1. Shiyu Zhang, Bowen Gong, Rong Tan, Yufen Liao, Xin Wang, Xu Wang, Ying Liu, Ting Liu, Jun Luo, Weiwei Li, Jia Yu, Ying Peng, Jiang Zheng. (2025) 8-Epidiosbulbin E acetate triggers apoptosis via metabolic activation-mediated crosstalk between mitochondria and endoplasmic reticulum. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, [PMID:40627913] [10.1016/j.ecoenv.2025.118614] |
| 2. Yufen Liao, Xin Wang, Guangyun Ran, Shiyu Zhang, Chutian Wu, Rong Tan, Ying Liu, Yan He, Ting Liu, Zhongxiu Wu, Ying Peng, Weiwei Li, Jiang Zheng. (2023) DNA damage and up-regulation of PARP-1 induced by columbin in vitro and in vivo. TOXICOLOGY LETTERS, [PMID:36905973] [10.1016/j.toxlet.2023.03.003] |
| 3. Shiyu Zhang, Ying Liu, Ting Liu, Jie Pan, Rong Tan, Zixia Hu, Bowen Gong, Yufen Liao, Peng Luo, Qibing Zeng, Weiwei Li, Jiang Zheng. (2022) DNA damage by reactive oxygen species resulting from metabolic activation of 8-epidiosbulbin E acetate in vitro and in vivo. TOXICOLOGY AND APPLIED PHARMACOLOGY, [PMID:35367474] [10.1016/j.taap.2022.116007] |
| 4. Xianya Qin, Conglian Yang, Hongbo Xu, Runzan Zhang, Dan Zhang, Jingyao Tu, Yuanyuan Guo, Boning Niu, Li Kong, Zhiping Zhang. (2021) Cell-Derived Biogenetic Gold Nanoparticles for Sensitizing Radiotherapy and Boosting Immune Response against Cancer. Small, 17 (50): (2103984). [PMID:34723421] [10.1002/smll.202103984] |
| 5. Zhongyin Chen, Lihui Wan, Ye Yuan, Ying Kuang, Xiangyu Xu, Tao Liao, Jia Liu, Zi-Qiang Xu, Bingbing Jiang, Cao Li. (2020) pH/GSH-Dual-Sensitive Hollow Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Cancer Therapy. ACS Biomaterials Science & Engineering, [PMID:33463161] [10.1021/acsbiomaterials.0c00073] |
| 6. Yan Jiang, Xiuzhen Wang, Xin Liu, Wei Lv, Hongjuan Zhang, Mingwan Zhang, Xinrui Li, Hongliang Xin, Qunwei Xu. (2016) Enhanced Antiglioma Efficacy of Ultrahigh Loading Capacity Paclitaxel Prodrug Conjugate Self-Assembled Targeted Nanoparticles. ACS Applied Materials & Interfaces, [PMID:27976583] [10.1021/acsami.6b13805] |
| 7. Min Zhang, Jia Liu, Ying Kuang, Qilin Li, Hongyu Chen, Haifeng Ye, Li Guo, Yanglin Xu, Xueqin Chen, Cao Li, Bingbing Jiang. (2016) “Stealthy” chitosan/mesoporous silica nanoparticle based complex system for tumor-triggered intracellular drug release. Journal of Materials Chemistry B, 4 (19): (3387-3397). [PMID:32263274] [10.1039/C5TB02548F] |
| 8. Dan Ma, Hai Zhang, An-ru Liao, Qian-rong Peng, Min Yang. (2025) A bifunctional drug delivery system with targeting and glutathione-responsivity amphiphiles for effective tumor therapy. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, [PMID:] [10.1016/j.jddst.2025.107041] |
| 9. Guangrong Zheng, Tengfei Ke, Hongjin Wang, Hong Huang, Ying Zhang, Guanghai Fei, Chengde Liao, Haiyan Yang. (2026) Tumor cell membrane camouflaged liposomal pharmaceuticals for cascade catalysis-driven redox modulation and synergistic ROS/RNS antitumor therapy. VIEW, [PMID:] [10.1002/VIW.20250198] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →
